Connect with us

Technology

Nordic and BeeKeeperAI partner to accelerate AI-driven clinical decision support at the point of care

Published

on

EHR implementation leader joins forces with leading innovator of privacy-preserving collaboration platform to accelerate real-world impact of clinical decision support systems (CDSS)RightAI was designed to enable life sciences companies to accelerate the development and deployment of CDSS to enable the right treatment for the right patient at the right time to improve outcomesNordic and BeeKeeperAI aim to enable hospitals, health systems, and academic medical centers to more efficiently test, deploy, and monitor clinical decision support at the point of care

MADISON, Wis., Oct. 17, 2024 /PRNewswire/ — Nordic®, a global health and technology consulting company, and BeeKeeperAI®, Inc. a pioneer in privacy-enhancing, multi-party collaboration software for real-world AI development and deployment, announced today a strategic partnership to bring to market a new real-world, end-to-end RightAI™ solution that is aimed at connecting biopharmaceutical and medical technology companies, healthcare delivery organizations, and physicians in the development, validation, and deployment of AI and machine learning-based CDSS tools that support clinical workflows within electronic health record (EHR) systems. The partnership intends for RightAI to assist physicians with optimizing patient outcomes through the use of native CDSS tools within the EHR and support efforts to identify patients who are optimal candidates for clinical trials.

Precise decision-making at the point of care can be difficult given a variety of factors, such as a patient’s unique clinical characteristics, chronic conditions, and the complexities of biological and disease factors. The development of a new standard of care resulting from the collaboration between biopharmaceutical and medical technology companies and healthcare systems can enable new personalized care programs, provide novel therapies, and meet patients’ goals for better health. RightAI seeks to offer solutions that enable clinicians to identify these optimal treatment plans for the right patient at the right time. Leveraging the power of data at the point of care from this collaboration can transform care delivery.

“By embracing AI in healthcare, we are transforming how care is delivered and setting a new standard for patient-centered, personalized, and efficient care,” said Nordic Chief Medical Officer Craig Joseph, MD. “Our partnership with BeeKeeperAI and the integration of RightAI into the EHR allows us to introduce AI models that create real-world impact and drive better patient outcomes.”

Along with the potential both to unlock data insights and enable more precise therapeutic decisions by clinicians, RightAI also intends to accelerate time-to-market for AI developers building CDSSs and other machine learning solutions for healthcare. Biopharmaceutical and medical technology companies offering therapies for complex diseases can leverage RightAI to assist with the development of CDSSs based on real-world data and quickly achieve real-world impacts.

“Together with Nordic, BeeKeeperAI’s privacy enhancing platform can address the last mile of AI/machine learning-based CDSS: real-world deployment and ongoing monitoring for performance drift. The ability to develop and deploy solutions in real-world settings enhances and accelerates the impact of CDSS,” said Michael Blum, MD, co-founder and chief executive officer at BeeKeeperAI. “Instead of taking years to achieve impact, RightAI will enable CDSS to impact patient outcomes in a matter of months from the start of development to impact. This acceleration will enable life-changing therapies to reach patients more quickly, fulfilling the promise of healthcare AI.”

Dr. Joseph added, “Following the guiding principles of clinical decision support, RightAI brings the right information to the right provider in the right format through the right channels at the right time to help clinicians improve the precision of their treatment decisions for their patients.”

The partnership continues Nordic and BeeKeeperAI’s leadership in the healthcare AI space. Nordic is a comprehensive delivery partner of BeeKeeperAI’s EscrowAI™, a privacy-enhancing collaboration platform for trustworthy and responsible AI that enables data controllers to maintain control and protect the privacy of their real-world patient data and developers to responsibly develop and deploy AI into the EHR and clinical workflows.

About Nordic Consulting
Nordic is a global health and technology consulting company that partners with health leaders worldwide to create healthier systems, organizations, and people. Our team of 3,300+ professionals bring decades of experience in strategic advisory, digital and cloud initiatives, implementation and support, ERP services, and managed services. The Nordic global team, including its Canadian arm Healthtech, support more than 700 clients in their efforts to harness the power of technology. Learn more at NordicGlobal.com

About BeeKeeperAI
BeeKeeperAI is a pioneer in privacy-enhancing technologies, leveraging Trusted Execution Environments with confidential computing for the development and deployment of AI in healthcare and other regulated data industries. BeeKeeperAI is accelerating the broader availability of AI-powered solutions that will help to redefine the future of healthcare and commerce. Learn more at BeeKeeperAI.com.   

Disclaimer:
Certain information herein contains forward-looking statements, and undue reliance should not be placed on them. Although forward-looking statements contained in this Press Release are based upon reasonable assumptions by management of both companies, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ from those anticipated in such statements.

Media Contact: 
Melissa Prusher, Nordic 
globalmarketing@nordicglobal.com  

View original content to download multimedia:https://www.prnewswire.com/news-releases/nordic-and-beekeeperai-partner-to-accelerate-ai-driven-clinical-decision-support-at-the-point-of-care-302279483.html

SOURCE Nordic Consulting

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and Positioning Company for Expansion in Renewable and Nutritional Energy Markets

Published

on

By

Barrel Energy Inc. (OTC: BRLL) A fully reporting company. Accelerates Growth Across Energy, Hospitality, and Sustainable Ventures, Driving Scalable Opportunities Worldwide.

LAS VEGAS, May 11, 2026 /PRNewswire/ — Barrel Energy Inc. (OTC: BRLL), an emerging diversified energy company focused on renewable energy and nutritional energy initiatives, today announced that the Company is now a fully reporting company with the U.S. Securities and Exchange Commission (“SEC”), marking a major turning point in the Company’s long term growth strategy and public market development.

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and positioning for Expansion.

“Our transition to becoming a fully reporting SEC company represents a significant milestone for Barrel Energy and an important step toward increasing the overall marketability and visibility of our stock,” said Jarmin Kaltsas. “We believe today’s market increasingly rewards transparency and compliance, and becoming fully reporting positions us to engage a wider audience of investors, strategic partners, and acquisition opportunities as we continue executing our long term growth strategy under the BRLL trading symbol.”

Management further stated that the Company plans to aggressively pursue growth initiatives intended to expand revenues, strengthen market presence, and enhance shareholder value through strategic business combinations, operational expansion, and scalable energy focused ventures.

About Barrel Energy Inc.

Barrel Energy Inc. (OTC: BRLL) is a diversified energy company focused on opportunities in renewable energy, and nutritional energy initiatives. The Company seeks to leverage strategic acquisitions, public market growth, and innovative energy solutions to create long term shareholder value.

Forward-Looking Statements:

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission.

Barrel Energy – 3859 S. Valley View Blvd, STE 2 #107, Las Vegas, NV, 89103 Tel- 888- 397-9114 Email- info@BRLLenergy.com Social Media-@BRLLenergy all platforms.

View original content:https://www.prnewswire.com/news-releases/barrel-energy-inc-announces-full-sec-reporting-status-strengthening-marketability-and-positioning-company-for-expansion-in-renewable-and-nutritional-energy-markets-302768505.html

SOURCE Barrel Energy, Inc.

Continue Reading

Technology

Legacy Launches $1M Study Advancing At-Home Semen Collection for Assisted Reproduction Technology

Published

on

By

NEW YORK, May 11, 2026 /PRNewswire/ — Legacy, the leading male fertility clinic and at-home sperm testing and cryopreservation platform, today announced the Sperm Study, a clinical research initiative backed by an R&D investment of over $1 million and designed to evaluate and optimize the use of at-home semen collection for assisted reproductive technologies (ART), including IVF and IUI.

Prospectively enrolling up to 250 participants across two phases, this study represents one of the most comprehensive investigations to date into how specimen shipment, handling, and cryopreservation impact sperm quality and is expected to set a new benchmark for scientific rigor in the rapidly growing field of at-home fertility testing. This study is being conducted in collaboration with IVF Academy USA.

Raising the bar for clinical evidence in at-home fertility care

To date, validation work in at-home semen collection has been limited in important ways. Studies have largely enrolled normozoospermic men only, relied on courier-transported rather than real-world-shipped specimens, and focused on short-term motility and concentration as primary endpoints.

Critical questions remain unanswered, particularly around how samples with varying quality perform under genuine end-to-end shipping conditions, and how those samples hold up in the contexts that matter most clinically: IVF and IUI. The Sperm Study is designed to close those gaps.

This multi-phase study will evaluate key sperm quality parameters including motility, DNA fragmentation, and post-thaw viability, while also validating the use of computer-aided semen analysis (CASA) as an alternative to basic manual semen analysis in the setting of mail-in semen analysis.

“With the increased utilization of at-home semen testing and cryopreservation, there is a critical need to ensure these specimens will perform adequately when used for assisted reproduction,” said Legacy’s Chief Medical Officer, Dr. Scott Lundy. “This study is designed to rigorously evaluate how at-home collection and transport impact sperm quality across a broad patient population and to translate those findings into improved protocols and optimized outcomes for both patients and providers.”

Sperm study design and scientific approach

The Sperm Study is a prospectively accruing cross-sectional study in which paired semen samples are analyzed across multiple timepoints and during the shipment process. Importantly, this study enrolls participants across a range of semen quality profiles — not solely normozoospermic men — and evaluates samples under genuine shipping conditions experienced by real specimens.

Key study components include direct comparison of CASA vs. manual analysis at baseline, evaluation of motility decline over time and in relation to shipment conditions, measurement of DNA fragmentation pre- and post-shipment and cryopreservation, assessment of post-thaw sperm viability and yield, and the development of predictive algorithms for IVF/IUI sample sufficiency.

The study will also examine how factors such as transit time, concentration, and storage conditions impact outcomes, with the goal of generating generalizable insights for clinical practice.

Multi-phase rollout

Phase 1 includes 100 participants and approximately 1,500 total assays, with expected completion in 2026. Phase 2, planned for later in 2026 and into 2027, will expand the study with additional participants, bringing the total to up to 250 to enable broader validation across a more diverse patient population.

Impact on clinical practice

Findings from the Sperm Study are expected to directly inform and improve specimen collection protocols for at-home use, shipping and handling standards for semen samples, cryopreservation practices, and clinical decision-making for IVF and IUI readiness.

By generating high-quality, controlled data across a clinically representative patient population, Legacy aims to provide fertility clinics, researchers, and patients with greater confidence in the use of mail-in semen testing and cryopreservation as part of standard reproductive care.

About Legacy

Legacy is the leading male fertility clinic in the United States, offering at-home semen analysis, sperm cryopreservation, and post-vasectomy testing. With a CLIA-certified, high-complexity andrology lab and one of the largest proprietary datasets in male reproductive health, Legacy is advancing access, data, and innovation in fertility care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-launches-1m-study-advancing-at-home-semen-collection-for-assisted-reproduction-technology-302768508.html

SOURCE Give Legacy, Inc.

Continue Reading

Technology

Elks Award Nearly $5 Million in College Scholarships

Published

on

By

CHICAGO, May 11, 2026 /PRNewswire/ — The Elks National Foundation welcomed 900 students to the Elks family, awarding more than $4.9 million in scholarships to high school seniors. An Elks scholarship is more than financial aid; it’s an invitation to a network of service-minded peers and a promise that an Elks Lodge is always there with open arms.

Out of more than 23,000 applicants for the Most Valuable Student scholarship, the Top 20 scholars received $30,000 scholarships and an invitation to Chicago for the Leadership Weekend.

From April 30-May 3, the Leadership Weekend allowed scholars to get acquainted with their new Elks family through programming facilitated by current and former Elks scholars, team-building activities, and a service opportunity.

“Leadership Weekend is one of my greatest memories,” says Emily Cai, sponsored by Toccoa, Ga., Lodge No. 1820. “I had the privilege of meeting inspirational and disciplined individuals who motivated me to become the best version of myself. I am excited to see my future with the Elks family!”

A total of 480 runners-up received $4,000 Most Valuable Student scholarships.

Service is a tenet of the Elks, which is why it’s a requirement for recipients of the $6,000 Legacy Awards scholarship, which is exclusively for the children or grandchildren of Elks members. The new class of 400 scholars will serve with an Elks Lodge three times during the four years they receive the scholarship.

“This award means a great deal to me and my family,” says Kelly Butler, sponsored by Haverstraw, N.Y., Lodge No. 877. “Knowing that the Elks have invested in my future motivates me to continue working hard and striving toward my goals.”

To see a full list of the scholarship winners and to learn more about the Elks National Foundation’s scholarships, visit elks.org/scholars, follow the ENF on Instagram @ElksScholars, and like the ENF on Facebook @ElksNationalFoundation.

Contact: Elks National Foundation
Abbey Knupp | Manager, Communications
2750 N. Lakeview Ave. | Chicago, IL 60614-2256
773/755-4864 | AbbeyK@elks.org 

Helping Elks Build Stronger Communities

The Elks National Foundation, the charitable arm of the Benevolent and Protective Order of Elks, helps nearly 800,000 Elks and nearly 1,800 Lodges nationwide build stronger communities through programs that support youth, serve veterans, and meet needs in areas where Elks live and work. To learn more, visit elks.org/enf.

View original content to download multimedia:https://www.prnewswire.com/news-releases/elks-award-nearly-5-million-in-college-scholarships-302768507.html

SOURCE ELKS NATIONAL FOUNDATION, INC.

Continue Reading

Trending